We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Rubber-Stoppered Vials Pose Latex Allergy Risk

By HospiMedica staff writers
Posted on 05 Jul 2001
A study has found that drugs stored in vials with a natural rubber stopper can be contaminated with latex allergens, no matter what precautions are taken. More...
The study, conducted by researchers at Johns Hopkins University (Baltimore, MD, USA), was published in the June 2001 issue of the Journal of Allergy and Clinical Immunology.

The researchers are asking drug manufacturers to label all current vials as "containing natural rubber” where appropriate and to convert to synthetic rubber for all future medicine bottle stoppers. The study involved 12 allergic and 11 non-allergic volunteers. All underwent puncture and intradermal skin testing with solutions from drug vials, two with natural rubber latex stoppers and three with synthetic stoppers. Two latex-allergic subjects had skin reactions even when the rubber stopper was not punctured. Five had reactions when the stopper was punctured 40 times before testing, not an infrequent practice, since some vials contain multiple doses.

Non-allergic subjects had no reaction. Until the U.S. Food and Drug Administration (FDA) requires labeling of vials with rubber stoppers or requires that all stoppers be latex free, some sensitized individuals will be at risk for potentially serious or fatal allergic reaction. In the meantime, say the researchers, pharmacists need to contact the drug manufacturer, ask if a stopper is made of latex, and if necessary, ask the company if it can provide the pharmaceutical in a vial with a synthetic stopper.




Related Links:
Johns Hopkins

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.